Regenerative medicine in spinal cord
injuries (SCI) is proving to help the human
body create new cell and nerve connections
that are severed during this type of
injury. In a review of current scientific
research for
stem cell treatment
in SCI published this month in the Springer
journal Neurotheraputics, Dr. Michael
Fehlings and Dr. Reaz Vawda from the
Krembil Neuroscience Centre, Toronto
Western Hospital in Ontario, Canada,
provide evidence that supports researchers
moving beyond the lab to conduct human
clinical trials for stem
cells.
